Published in Nat Rev Clin Oncol on May 01, 2010
Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med (2009) 1.85
Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation. J Exp Med (2013) 1.47
Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken. Immunogenetics (2004) 1.32
Avian beta-defensin nomenclature: a community proposed update. Immunol Lett (2007) 1.12
Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors. Cancer Res (2011) 1.08
Absence of SHIP-1 results in constitutive phosphorylation of tank-binding kinase 1 and enhanced TLR3-dependent IFN-beta production. J Immunol (2010) 1.07
Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease? Nat Rev Immunol (2011) 1.01
Enhanced interferon regulatory factor 3 binding to the interleukin-23p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus erythematosus. Arthritis Rheum (2012) 0.93
Differential antimicrobial peptide gene expression patterns during early chicken embryological development. Dev Comp Immunol (2008) 0.83
Osteoarthritis: Concentrated efforts to detect early OA. Nat Rev Rheumatol (2010) 0.77
Rheumatoid arthritis: Synergistic effects of growth factors drive an RA phenotype in fibroblast-like synoviocytes. Nat Rev Rheumatol (2010) 0.76
Pain: Diagnostic blocks—a pain in the back? Nat Rev Rheumatol (2010) 0.75
Public health: Ozone pollution—a link with cardiac and cerebral ischemic events? Nat Rev Cardiol (2011) 0.75
Spondyloarthropathies: Synergistic therapy protects bone in patients with AS. Nat Rev Rheumatol (2010) 0.75
Cell-bound proteins complement current screening options in patients with SLE. Nat Rev Rheumatol (2010) 0.75
Biliary tract: a new duct-to-duct reconstruction technique reduces biliary complications in LDLT. Nat Rev Gastroenterol Hepatol (2010) 0.75
Imaging: Fractal analysis for CHD mortality. Nat Rev Cardiol (2011) 0.75
Screening: A re-evaluation of KRAS mutational 'hotspots'. Nat Rev Clin Oncol (2010) 0.75
Osteoporosis: Zoledronic acid for osteoporosis treatment--a matter of time. Nat Rev Rheumatol (2010) 0.75
Prevention: Supplements not cardioprotective for patients with a history of CVD. Nat Rev Cardiol (2011) 0.75
Interventional cardiology: DES safe in large arteries. Nat Rev Cardiol (2011) 0.75
PTPRC mutation associated with response to anti-tNF therapy in rheumatoid arthritis. Nat Rev Rheumatol (2010) 0.75
Osteoarthritis: HIF-2alpha drives osteoarthritis development. Nat Rev Rheumatol (2010) 0.75
Rheumatoid arthritis: Immunogenicity is predictive of future treatment success in RA. Nat Rev Rheumatol (2011) 0.75